EU Agrees Vaccine Delivery Acceleration with Pfizer
The European Commission has agreed with BioNtech-Pfizer to accelerate the delivery of its mRNA vaccine to Member States, starting in
All posts in Vaccine
The Delta Variant Exposes Europe’s Urgent Need for Covid-19 Treatments
The French government has announced severe new restrictions on the unvaccinated come August after the Delta variant surged to represent
Study: BioNTech Vaccine Could Protect Longer Than Anticipated
A US study suggests that BioNTech / Pfizer’s vaccine could protect against the coronavirus for a long time. B memory
Denmark Relaxes Lockdown Restrictions for Citizens and Travellers
After months of lockdown, Denmark has slowly begun to relax its restrictions, beginning after Easter where students were gradually allowed
EMA finds possible link between Johnson & Johnson Vaccine and Very Rare Blood Clots
The European Medicines Agency safety committee (PRAC) has concluded that a warning about unusual blood clots with low blood platelets
WHO Troubled Vaccine May Not Work on New Strain
The World Health Organization (WHO) on Friday expressed concern that manufactured vaccines against the coronavirus disease (COVID) may not work
EU Has Handled the COVID-19 Pandemic Well, Like Any Other Crisis It Wasn’t Built For
Bashers, haters, and doomsayers for the EU seem to be among the most constant, resilient, and determined actors in the
EU Members Criticized for Slow Rollout of Vaccine
Members of the European Union (EU) have been called out for their sluggish rollout of the coronavirus vaccine as their
UK Warns Allergic People Versus Buying Pfizer Vaccine
The United Kingdom’s (UK) medicine regulator has advised people with allergies do not get Pfizer-BioNTech’s vaccine against coronavirus disease-2019 (COVID-19).
Moderna Seeks Regulator Approval for Vaccine Use
Pharmaceutical giant Moderna, one of the participants in the manufacture of a cure against the coronavirus disease-2019 (COVID-19), has sought
Oxford: Late-Stage Trial Results for Potential Vaccine ‘Likely This Year’
The University of Oxford was hoping to present within the year the results of its late-stage trial on a potential